Delivery Order SPE2DB20D1100-SPE2DB25FD8E9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,463.30 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Xulane 150-35 microgram/day contraceptive patches (3-pack). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 5, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,138.34 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count units). This firm fixed-price, competitively awarded delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.57 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-pack units). This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 11, 2025. The delivery location is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,691.42 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count packaging). This is a firm fixed-price, non-set-aside contract with a completion date of August 8, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to the vendor's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $3,988.76 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count). This firm fixed-price, competitively awarded contract was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,341.69 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count package) on July 23, 2025, with completion due July 24, 2025. This is an unset-aside, competitively awarded contract performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a transactional purchase of pharmaceutical products within AmerisourceBergen's existing federal...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $52,005.94 to AmerisourceBergen Drug Corp for Xulane 150-35mcg contraceptive patches. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 22, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible vendors. This...
- The Defense Logistics Agency awarded a $2,169.97 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Xulane 150-35 mcg/day contraceptive patches (3-count units). The contract is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and represents a non-set-aside competitive award. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,428.13 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack units). This competitively awarded, non-set-aside delivery order reflects firm fixed pricing and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a $1,299.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (quantity: 3 units) on July 21, 2025, with completion scheduled for July 22, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger contract vehicle. The pharmaceutical product will be delivered to the company's distribution center in Conshohocken, Pennsylvania. This delivery...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD8E9Delivery Order
The Defense Logistics Agency awarded a $12,219.05 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (quantity of 3 units). This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and completion scheduled for August 5, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle that extends through December 2026 and enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical requirements through competitive procurement, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order represents a routine transaction within the company's broader role as a primary pharmaceutical vendor supporting military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 8/4/25 |